Literature DB >> 8984741

Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action.

T Trapp1, F Holsboer.   

Abstract

Gene regulation by steroids is mediated by the binding of the endogenous or pharmacological ligand to the corresponding nuclear receptor. Ligand-activated steroid receptors usually regulate the expression of responsive genes by binding to common response elements on DNA as homodimers. However, recent findings indicate that mineralocorticoid and glucocorticoid receptors are able to interact by forming heterodimers. In tissues coexpressing both of these corticosteroid receptors, heterodimerization between them may be a hitherto unrecognized modality for the transcriptional regulation of corticosteroid-responsive genes. In this review, Thorsten Trapp and Florian Holsboer discuss the potential impact of this heterodimerization on corticosteriod physiology and pharmacology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8984741     DOI: 10.1016/0165-6147(96)81590-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  26 in total

1.  Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts.

Authors:  K Rombouts; A Wielant; K Hellemans; D Schuppan; A Geerts
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Hippocampal cell responses in mice with a targeted glucocorticoid receptor gene disruption.

Authors:  W Hesen; H Karst; O Meijer; T J Cole; W Schmid; E R de Kloet; G Schütz; M Joëls
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

Review 3.  Gender specificity in the neural regulation of the response to stress: new leads from classical paradigms.

Authors:  V K Patchev; O F Almeida
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

Review 4.  Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor.

Authors:  Daniel M Cohen; David J Steger
Journal:  Trends Endocrinol Metab       Date:  2017-05-08       Impact factor: 12.015

Review 5.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

6.  Dexamethasone stimulates endothelin-1 gene expression in renal collecting duct cells.

Authors:  Lisa R Stow; George E Voren; Michelle L Gumz; Charles S Wingo; Brian D Cain
Journal:  Steroids       Date:  2011-12-19       Impact factor: 2.668

7.  Expression of alpha(1b) adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone.

Authors:  H E Day; S Campeau; S J Watson; H Akil
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

8.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Vasopressin potentiates mineralocorticoid selectivity by stimulating 11 beta hydroxysteroid deshydrogenase in rat collecting duct.

Authors:  N Alfaidy; M Blot-Chabaud; J P Bonvalet; N Farman
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.

Authors:  Rob W J Collin; Ersan Kalay; Muhammad Tariq; Theo Peters; Bert van der Zwaag; Hanka Venselaar; Jaap Oostrik; Kwanghyuk Lee; Zubair M Ahmed; Refik Caylan; Yun Li; Henk A Spierenburg; Erol Eyupoglu; Angelien Heister; Saima Riazuddin; Elif Bahat; Muhammad Ansar; Selcuk Arslan; Bernd Wollnik; Han G Brunner; Cor W R J Cremers; Ahmet Karaguzel; Wasim Ahmad; Frans P M Cremers; Gert Vriend; Thomas B Friedman; Sheikh Riazuddin; Suzanne M Leal; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.